Thai Health Advocates Work to Protect Special Provisions on Medicines Under E.U. Free Trade Agreement
January 3, 2013
Thailand and the European Union (E.U.) are expected to begin talks on a free trade agreement early this year, and Thai public health advocates have sent a letter to Joao Aguiar Machado, deputy director general for trade at the European Commission, "call[ing] for the bloc to respect global trade rules' special provisions for developing countries," Inter Press Service reports. "'We are worried that the E.U. negotiators will force Thailand to accept new conditions on patents that would make access to new generic drugs more difficult,' says Chalermsak Kittitrakul, campaign officer at the AIDS Access Foundation," the news service writes, adding, "Thai health activists are hoping that their record of mounting successful campaigns against pharmaceutical giants -- even from the United States -- to ensure a thriving generic drugs market for patients in the country and across the region remains intact" (Macan-Markar, 12/29).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)